Data management and design issues in an unmasked randomized trial of electroconvulsive therapy for relapse prevention of severe depression: the consortium for research in electroconvulsive therapy trial.

Data management and design issues in an unmasked randomized trial of electroconvulsive therapy for relapse prevention of severe depression: the consortium for research in electroconvulsive therapy trial. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Data management and design issues in an unmasked randomized trial of electroconvulsive therapy for relapse prevention of severe depression: the consortium for research in electroconvulsive therapy trial. Abstract Text:

Keith G Rasmussen,Rebecca G Knapp,Melanie M Biggs,Glenn E Smith,Teresa A Rummans,Georgios Petrides,Mustafa M Husain,M Kevin O'Connor,Max Fink,Charles H Kellner,

BACKGROUND: The use of double-blind designs, normally the criterion standard of clinical trials, is impossible when comparing medication therapy to procedural therapies for depression. In the Consortium for Research in Electroconvulsive Therapy (CORE) trial, depressed patients recently remitted with electroconvulsive therapy (ECT) were randomly assigned to receive continuation therapy with either ECT or medications. The purpose of this article is to describe the design characteristics and challenges of the trial and of our method of dealing with the lack of double-blind outcome assessment. METHODS: The primary outcome measure was time to relapse of depression in the continuation phase. We developed a method to achieve partial blinding of depressive severity assessment. This consisted of videotaping the structured interviews, having the video tapes co-rated by personnel not involved in the patient's care, and a videotape-tracking maneuver so that the assessor of the videotapes could be blinded to phase and type of treatment. RESULTS: We enrolled 624 patients into the initial treatment phase of the trial. Of these, 201 met criteria for randomization into the second, continuation phase. Our videotape-tracking maneuver to reduce bias in outcome assessment worked well during the trial. CONCLUSIONS: The CORE study is the first multicenter, randomized controlled trial of continuation ECT in the relapse prevention of major depressive episodes. We successfully recruited a large number of severely depressed patients into a 6 month trial and used a method of reducing bias that might result from lack of blinding.

Data management and design issues in an unmasked randomized trial of electroconvulsive therapy for relapse prevention of severe depression: the consortium for research in electroconvulsive therapy trial. Publishing Authors By Initials

KG Rasmussen,RG Knapp,MM Biggs,GE Smith,TA Rummans,G Petrides,MM Husain,MK O'Connor,M Fink,CH Kellner,

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

Data management and design issues in an unmasked randomized trial of electroconvulsive therapy for relapse prevention of severe depression: the consortium for research in electroconvulsive therapy trial. Journal Published:

PUBLICATION TYPE: Research Support, N.I.H., Extr

Journal: The journal of ECT

VOLUME: 23

Page Numbers: 244-50

Journal Abbreviation:

ISSN: 1095-0680

DAY: 19

MONTH: Dec

YEAR: 2007

Data management and design issues in an unmasked randomized trial of electroconvulsive therapy for relapse prevention of severe depression: the consortium for research in electroconvulsive therapy trial. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 9808943

Data management and design issues in an unmasked randomized trial of electroconvulsive therapy for relapse prevention of severe depression: the consortium for research in electroconvulsive therapy trial. Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: Data management and design issues in an unmasked randomized trial of electroconvulsive therapy for relapse prevention of severe depression: the consortium for research in electroconvulsive therapy trial. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for Data management and design issues in an unmasked randomized trial of electroconvulsive therapy for relapse prevention of severe depression: the consortium for research in electroconvulsive therapy trial.

AFFILIATION: Department of Psychiatry and Psychology, Mayo Clinic, Rochester, MN 55905, USA. rasmussen.keith@mayo.edu

Country: United States

AGENCY: United States NIMH

GRANT: MH-55495

ACRONYM: MH

MEDLINETA: J ECT

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Data management and design issues in an unmasked randomized trial of electroconvulsive therapy for relapse prevention of severe depression: the consortium for research in electroconvulsive therapy trial Related Publications

• A combined dexamethasone/corticotropin-releasing hormone test in patients with chronic PTSD - First preliminary results.
• A new Cretaceous terrestrial ecosystem from Gondwana with the description of a new sauropod dinosaur.
• Alzheimer's disease, the potential use of a bacterium in rice production, and the paleochannels of the Marajó Island.
• Antidepressant medication treatment failure does not predict lower remission with ECT for major depressive disorder: a report from the consortium for research in electroconvulsive therapy.
• Artificial hazards in prescribing.
• Beliefs and behaviours of parents regarding antibiotic use by children.
• Candidate biomarkers in renal cell carcinoma.
• Cognitive tolerability of electroconvulsive therapy in a patient with a history of traumatic brain injury.
• DSM melancholic features are unreliable predictors of ECT response: a CORE publication.
• Data management and design issues in an unmasked randomized trial of electroconvulsive therapy for relapse prevention of severe depression: the consortium for research in electroconvulsive therapy trial.
• Determination of free medium-chain fatty acids in beer by stir bar sorptive extraction.
• Global climate change and dengue.
• How knowledge of regional brain dysfunction in depression will enable new somatic treatments in the next millennium.
• Imaging and the perspective of clinical electrophysiology.
• Pharmacologic and antitumor effects of 1,2:5,6-dianhydrogalactitol (NSC-132313).
• Relationship between somatization and remission with ECT.
• The efficacy of acute electroconvulsive therapy in atypical depression.
• The significance of somatization.
• The successful use of electroconvulsive therapy in a patient with interferon-induced psychotic depression.
• Thiothixene in the treatment of geriatric patients with chronic organic brain syndrome.
• [Certain problems of the pathology of stomach cancer.]
• [Clinical experiences with a new phenothiazine-containing soporific.]
• [Detection of immune complexes in intrauterine retardation]
• [Double-timed sphincter transsection for therapy of anal fistula and the risk of sphincter insufficiency.]
• [Not Available.]
• [Not Available.]
• [Not Available.]
• [Not Available.]
• [Recommendation for vitamin K administration for the prevention of hemorrhage caused by vitamin K deficiency]
• [Therapy of pyuria in children.]